Feldene (piroxicam) was discontinued primarily due to the availability of newer, safer NSAIDs (non-steroidal anti-inflammatory drugs) with fewer side effects. Manufacturers chose to focus resources on these newer medications, offering comparable or superior pain relief with a reduced risk of serious adverse events.
Safety Concerns with Piroxicam
Piroxicam, the active ingredient in Feldene, carries a higher risk of gastrointestinal complications, including ulcers and bleeding, compared to many newer NSAIDs. This increased risk, coupled with the availability of safer alternatives, led to its market withdrawal. Furthermore, studies have shown a greater risk of cardiovascular events with prolonged use of piroxicam. These safety concerns directly influenced the decision to discontinue the drug.
Alternatives to Feldene
Patients previously using Feldene should consult their doctor to discuss appropriate alternative medications. Numerous NSAIDs, as well as other pain management options, are available today. Your doctor will help select a treatment plan tailored to your specific needs and medical history, minimizing potential risks and maximizing therapeutic benefits. This transition is crucial for patient safety.
